BioMarin cuts ~120 jobs, expects $50M annual savings to reinvest

BIOMARIN PHARMACEUTICAL INC

Workforce reduction of ~120 employees; pre-tax charges of $20-25M in Q3/Q4 2022.
Expected annualized cost savings ~$50M; savings to be reinvested in operations to boost profitability.
Majority of reductions announced Oct 6, 2022; substantially complete by Dec 31, 2022.

item 2.05

BIOMARIN PHARMACEUTICAL INC filing history →

Source: SEC EDGAR

accession 0001193125-22-259009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.